Logo

Coda Genomics, Genencor Sign Screening Agreement

Oct 15, 2008
NEW YORK (GenomeWeb News) – Synthetic biology company Coda Genomics said yesterday that it has signed a collaborative agreement with biotechnology company Genencor, a division of Danish firm Danisco.
 
Under the agreement, Coda will use its proprietary approach to develop synthetic gene and protein libraries, which will be screened for use in future research programs by Genencor. Financial terms of the agreement were not disclosed.
 
Genencor develops and markets enzyme and bio-based products for industrial biotechnology, while Coda applies synthetic technologies to create new genes, proteins, and organisms for bioindustrial and life sciences applications.

Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.